B
Barinthus Biotherapeutics plc (BRNS)
NGM – Real Time Price. Currency in USD
0.70
-0.02 (-2.64%)
At close: Jun 26, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
0.70
-0.02 (-2.64%)
At close: Jun 26, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $67.2M significantly exceed its total debt $11.0M, ensuring strong financial flexibility
Total current assets $72.7M exceed Total current liabilities $12.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-405.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.4M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.05 | 6.05 | 10 | |
| Quick ratio | 6.05 | 5.63 | 10 | |
| Debt to Equity | 0.17 | 0.30 | 9.0 | |
| Debt to Assets | 0.12 | 1.04 | 8.0 | |
| Interest coverage | -405.38 | -16.91 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 45M | 805K | 15M | N/A | N/A |
| Gross Profit | N/A | -5M | 9M | -6M | -5M |
| Operating Income | -28M | -92M | -55M | -54M | -38M |
| Net Income | 5M | -74M | -61M | -67M | -52M |
| EBITDA | -23M | -86M | -50M | -48M | -33M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 46.15 | 5.5 |
| Next quarter | N/A | 19.44 | 5.0 |
| Current year | N/A | 29.88 | 5.5 |
| Next year | N/A | 0 | 1.0 |
| Weighted average score | 4.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 50.14 | 48.15 | 19.93 | 9.8 |
| Y/Y | 999 | 72 | 71.43 | 77.54 | 10 |
| 3y average | 520.62 | -490.37 | -483.73 | -63.04 | 3.3 |
| 5y average | 3607.19 | -309.12 | -287.81 | -69.13 | 3.3 |
| Weighted average score | 6.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |